REVERSAL OF TOXICITY AND ANTITUMOR ACTIVITY OF N-(PHOSPHONACETYL)-L-ASPARTATE BY URIDINE OR CARBAMYL-DL-ASPARTATE INVIVO

被引:72
|
作者
JOHNSON, RK [1 ]
机构
[1] NCI,EXPTL CHEMOTHERAPY LAB,BETHESDA,MD 20014
关键词
D O I
10.1016/0006-2952(77)90137-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:81 / 84
页数:4
相关论文
共 50 条
  • [41] APPLICATION OF A SIMPLE COMPETITIVE-PROTEIN-BINDING ASSAY TECHNIQUE TO THE PHARMACOKINETICS OF N-(PHOSPHONACETYL)-L-ASPARTATE IN HUMANS
    ERLICHMAN, C
    STRONG, JM
    CHABNER, BA
    CANCER RESEARCH, 1980, 40 (06) : 1902 - 1906
  • [42] PENETRATION OF N-(PHOSPHONACETYL)-L-ASPARTATE INTO HUMAN CENTRAL NERVOUS-SYSTEM AND INTRA-CEREBRAL TUMOR
    STEWART, DJ
    LEAVENS, M
    FRIEDMAN, J
    BENJAMIN, RS
    MOORE, EC
    BODEY, GP
    VALDIVIESO, M
    BURGESS, MA
    WISEMAN, C
    LOO, TL
    CANCER RESEARCH, 1980, 40 (09) : 3163 - 3166
  • [43] PERIPHERAL LEUKOCYTES AS INDICATORS OF THE ENZYMATIC EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) ON HUMAN L-ASPARTATE TRANSCARBAMOYLASE (ATCASE) ACTIVITY
    KENSLER, TW
    ERLICHMAN, C
    JAYARAM, HN
    TYAGI, AK
    ARDALAN, B
    COONEY, DA
    CANCER TREATMENT REPORTS, 1980, 64 (8-9): : 967 - 973
  • [44] N-(PHOSPHONACETYL)-L-ASPARTATE, A POTENT TRANSITION-STATE ANALOG INHIBITOR OF ASPARTATE-TRANSCARBAMYLASE, BLOCKS PROLIFERATION OF MAMMALIAN-CELLS IN CULTURE
    SWYRYD, EA
    SEAVER, SS
    STARK, GR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1974, 249 (21) : 6945 - 6950
  • [45] EFFECT OF N-(PHOSPHONACETYL)-L-ASPARTATE ON 5-AZACYTIDINE METABOLISM IN P388 AND L1210 CELLS
    GRANT, S
    RAUSCHER, F
    JAKUBOWSKI, A
    CADMAN, E
    CANCER RESEARCH, 1981, 41 (02) : 410 - 418
  • [46] COMPARATIVE PHYSIOLOGICAL DISPOSITION OF N-(PHOSPHONACETYL)-L-ASPARTATE IN SEVERAL ANIMAL SPECIES AFTER INTRAVENOUS AND ORAL-ADMINISTRATION
    CHADWICK, M
    SILVEIRA, DM
    MACGREGOR, JA
    BRANFMAN, AR
    LISS, RH
    YESAIR, DW
    CANCER RESEARCH, 1982, 42 (02) : 627 - 632
  • [47] STRUCTURE OF AMPLIFIED DNA IN DIFFERENT SYRIAN-HAMSTER CELL-LINES RESISTANT TO N-(PHOSPHONACETYL)-L-ASPARTATE
    ARDESHIR, F
    GIULOTTO, E
    ZIEG, J
    BRISON, O
    LIAO, WSL
    STARK, GR
    MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (11) : 2076 - 2088
  • [48] MODULATION OF HUMAN OVARIAN TUMOR-CELL SENSITIVITY TO N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) BY LIPOSOME DRUG CARRIERS
    SHARMA, A
    STRAUBINGER, NL
    STRAUBINGER, RM
    PHARMACEUTICAL RESEARCH, 1993, 10 (10) : 1434 - 1441
  • [49] PHARMACOKINETICS OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5-FU) COMBINATION IN BEAGLE DOGS
    MILLER, AA
    MOORE, EC
    LOO, TL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 245 - 245
  • [50] N-(PHOSPHONOACETYL)-L-ASPARTATE (PALA) CONCENTRATION AND ASPARTATE CARBAMOYLTRANSFERASE (ACTASE) ACTIVITY IN BIOPSY SPECIMENS OF PATIENTS TREATED WITH PALA
    MOORE, EC
    FRIEDMAN, J
    VALDIVIESO, M
    MARTI, JR
    RUSS, J
    LOO, TL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 221 - 221